Abstract
BackgroundGI-108 (anti-CD73-IL2v) is a novel immunocytokine designed to target immune and tumor cells expressing CD73. CD73 is the key ectoenzyme involved in the generation of AMP-derived adenosine, which contributes to...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have